Current Issue
Volume 1, Issue 1 (2026)
Cover: Tumor–microbiome interface. Illustration of microbial colonization at the surface of a malignant tumor mass, affecting inflammation, immune modulation, and therapeutic response.
Volume 1, Issue 1 (2026) of Cancer Biome and Targeted Therapy. This issue includes the official front matter as a PDF (journal information, editorial leadership, and publisher details). This is the inaugural issue of the journal.
Co-Editors-in-Chief:
Antoine Italiano, MD, PhD - Institut Bergonié Comprehensive Cancer Center, Bordeaux, France
Ubaldo Martinez-Outschoorn, MD, PhD - Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA
Peng Huang, PhD - Sun Yat-sen University Cancer Center, Guangzhou, China
Publisher Name: GCINC Press,
The offices of the publisher, GCINC Press, are located in Spokane, Washington, United States.
Publisher Address: GCINC Press, 522 W Riverside Ave, Suite N, Spokane, WA 99201, USA
Contact: submissions@cancerbiometherapy.com
Full Issue: Front Matter
Published:
2026-01-25
Full Issue
Review
Welcome to Cancer Biome and Targeted Therapy (CBTT)
Cancer Biome and Targeted Therapy (CBTT) is a peer-reviewed, open-access journal that focuses on multidisciplinary investigations of cancer signaling pathways, biomarkers, diagnostics, and therapeutic targets with an emphasis on the following disciplines:
- Oncology: Molecular and translational cancer research, tumor biology, disease progression, and therapeutic response.
- Immunology: Immune tumor microenvironment and host–tumor interactions.
- Microbiology: Microbial ecosystems, including bacterial, fungal, viral, and parasitic components, and their influence on the tumor niche.
- Biochemistry & Molecular Biology: Molecular cancer mechanisms, signaling, biomarkers, diagnostics, and therapeutic targets.
- Pharmacology and therapeutics: Resistance mechanisms and the development of precision and targeted therapies.
- Molecular Medicine: Molecular and genetic mechanisms underlying cancer initiation, progression, and therapy response.
Article Processing Charges:
Cancer Biome and Targeted Therapy does not charge submission fees, page charges, or article processing charges (APCs). All accepted articles are published open access, at no cost to authors.
Open Access License:
All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). https://creativecommons.org/licenses/by/4.0/.
Instructions for authors
Detailed information on manuscript preparation, article types, submission requirements, and peer review procedures is provided in the Instructions for Authors. View Instructions for Authors
Co-Editors-in-Chief:
Antoine Italiano, MD, PhD; Ubaldo Martinez-Outschoorn, MD, PhD; Peng Huang, PhD.
Co-Editors-in-Chief, Editorial Board members' contact is listed on the Editorial Board Team
ISSN: [Pending]
Publisher Information:
The publisher of this journal is GCINC Press.
The offices of the publisher are located in Spokane, Washington, United States.
Publisher Address:
GCINC Press
522 W Riverside Ave, Suite N
Spokane, WA 99201
United States
Publisher Contact Email: submissions@cancerbiometherapy.com.
